Abstract:Objective: To investigate the effect of chitosan combined with nanosilver on the wound recovery of patients with highgrade squamous intraepithelial lesion (HSIL) who underwent loop electrosurgical excision procedure (LEEP) treatment. Methods: A total of 160 patients who were admitted to the Fourth Affiliated Hospital of Jiangsu University from September 2020 to May 2021 pathologically diagnosed with HSIL and negative margins after LEEP treatment were enrolled in the study. Then the patients were randomly divided into control group, chitosan group, nanosilver group, combined group (chitosan combined nanosilver) and control group, with 40 cases in each group. Except for the control group, the other three groups were administrated with the corresponding treatment twice a week, for a total of 8 times. In each group within 2 months after the operation, the wounds after the operation, the cleanliness of the vaginal secretions in 2 weeks after the operation and postoperative complications were observed and recorded. ELISA was used to detect the content of inflammatory factors such as TNF-α, IL-6, IL-8 and highmobility group box 1 protein (HMGB1) in cervical secretions before and 1, 2, 3, 4 weeks after operation. Results: Compared with control group, the disappearance time of vaginal discharge, the time to scab off the wound, and the time of wound healing in the combined group were significantly reduced in chitosan group and nano-silver group(all P<0.05). Compared with the control group and the chitosan group, the incidence of lower abdominal pain and purulent secretions after operation in the combined group were greatly reduced(all P<0.05). Compared with the control group and the chitosan group, the content of HMGB1, TNF-α, IL-6 and IL-8 in combined group were significantly reduced in 1, 2, 3, 4 weeks after operation(all P<0.05). Compared with the nanosilver group, the content of HMGB1(1, 2, 4 weeks after operation), TNF-α (1, 2, 3, 4 weeks after operation), IL-6 (1, 2, 3 weeks after operation), IL-8(1, 3, 4 weeks after operation) in the combined group were remarkably decreased(all P<0.05). Conclusion: The combined application of chitosan and nanosilver could not only promote the healing of cervical wounds after LEEP treatment, but also prevent postoperative complications.
[1]Basu P, Taghavi K, Hu SY, et al. Management of cervical premalignant lesions[J]. Curr Probl Cancer, 2018, 42(2): 129-136.
[2]Zhang H, Lu J, Lu Y, et al. Cervical microbiome is altered in cervical intraepithelial neoplasia after loop electrosurgical excision procedure in China[J]. Sci Rep, 2018, 8(1): 4923.
[3]Kawahara R, Fujii T, Kukimoto I, et al. Changes to the cervicovaginal microbiota and cervical cytokine profile following surgery for cervical intraepithelial neoplasia[J]. Sci Rep, 2021, 11(1): 2156.
[4]Chamot E, Kristensen S, Stringer JS, et al. Are treatments for cervical precancerous lesions in lessdeveloped countries safe enough to promote scalingup of cervical screening programs? A systematic review[J]. BMC Womens Health, 2010, 10: 11.
[5]Kravanja G, Primoicˇ M, Knez , et al. Chitosanbased (Nano)materials for Novel Biomedical Applications[J]. Molecules, 2019, 24(10): 1960.
[6]Prasath S, Palaniappan K. Is using nanosilver mattresses/pillows safe? A review of potential health implications of silver nanoparticles on human health[J]. Environ Geochem Health, 2019, 41(5): 2295-2313.
[7]Franci G, Falanga A, Galdiero S, et al. Silver nanoparticles as potential antibacterial agents[J]. Molecules, 2015, 20(5): 8856-8874.
[8]Mezzana P. Clinical efficacy of a new chitin nanofibrilsbased gel in wound healing[J]. Acta Chir Plast, 2008, 50(3): 81-84.
[9]Baldrick P. The safety of chitosan as a pharmaceutical excipient[J]. Regul Toxicol Pharmacol, 2010, 56(3): 290-299.
[10]单丹彤,谢飞,李若慧.壳聚糖的生物医学特性与其结构的关系研究进展[J].化工新型材料, 2012, 40(6): 19-21.
[11]Li J, Feng X, Liu B, et al. Polymer materials for prevention of postoperative adhesion[J]. Acta Biomater, 2017, 61: 21-40.
[12]NogueiraMachado JA, de Oliveira Volpe CM. HMGB1 as a target for inflammation controlling[J]. Recent Pat Endocr Metab Immune Drug Discov, 2012, 6(3): 201-209.
[13]Andersson U, Wang H, Palmblad K, et al. High mobility group 1 protein (HMG1) stimulates proinflammatory cytokine synthesis in human monocytes[J]. J Exp Med, 2000, 192(4): 565-570.
[14]Muzzarelli RA. Chitins and chitosans as immunoadjuvants and nonallergenic drug carriers[J]. Mar Drugs, 2010, 8(2): 292-312.
[15]Peluso G, Petillo O, Ranieri M, et al. Chitosanmediated stimulation of macrophage function[J]. Biomaterials, 1994, 15(15): 1215-1220.
[16]殷新明,朱小兰,温坚,等. 宫颈锥形切除术后宫颈组织中TNFα、IL6、HMGB1的表达及其意义研究[J].重庆医学, 2017, 46(11): 1472-1475.
[17]Slawson RM, Lee H, Trevors JT. Bacterial interactions with silver[J]. Biol Met, 1990, 3(3-4): 151-154.
[18]Vaidyanathan R, Kalishwaralal K, Gopalram S, et al. Nanosilver—the burgeoning therapeutic molecule and its green synthesis[J]. Biotechnol Adv, 2009, 27(6): 924-937.
[19]Agarwal A, Weis TL, Schurr MJ, et al. Surfaces modified with nanometerthick silverimpregnated polymeric films that kill bacteria but support growth of mammalian cells[J]. Biomaterials, 2010, 31(4): 680-690.